Literature DB >> 26247842

Blister roof grafting, cultured melanocytes transplantation and non-cultured epidermal cell suspension transplantation in treating stable vitiligo: A mutual self-control study.

Huaye Bao1, Weisong Hong1, Lifang Fu1, Xiaodong Wei1, Guopei Qian1, Aie Xu1.   

Abstract

OBJECTIVES: To compare the efficacy of blister roof grafting (BG), cultured melanocytes transplantation (CMT) and non-cultured epidermal cell suspension transplantation (NCES) in the treatment of stable vitiligo.
METHODS: In each person of 83 vitiligo patients one vitiligo macule was selected and divided in three areas for separate treatment with BG, CMT and NCES in the same session. The results were evaluated 12-month post-surgery for the extent of repigmentation and color match.
RESULTS: A satisfactory result (>50% repigmentation) was achieved in 92%, 82% and 81% of the 83 patients with the BG, CMT and NCES methods, respectively. Significant differences between the BG and CMT groups (p = 0.038), and between BG and NCES groups (p = 0.017) were observed, but not between the CMT and NCES groups (p = 0.986). The extent of repigmentation on the head neck and trunk was superior to that of the extremities by all the three methods. A difference in the time of onset of repigmentation was observed, with repigmentation first appearing after 10 days, 20-30 days and >30 days in the BG, CMT and NCES groups, respectively.
CONCLUSIONS: All the three methods are safe and effective to treat vitiligo. Future studies with larger groups are warranted to confirm our results.

Entities:  

Keywords:  BG; CMT; NCES; vitiligo

Mesh:

Year:  2015        PMID: 26247842     DOI: 10.3109/09546634.2015.1034068

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  6 in total

1.  Efficacy of Transplantation of Combination of Noncultured Dermal and Epidermal Cell Suspension vs Epidermal Cell Suspension Alone in Vitiligo: A Randomized Clinical Trial.

Authors:  Vishal Thakur; Sheetanshu Kumar; Muthu Sendhil Kumaran; Hitaishi Kaushik; Niharika Srivastava; Davinder Parsad
Journal:  JAMA Dermatol       Date:  2019-02-01       Impact factor: 10.282

2.  Epidermal skin grafting in vitiligo: a pilot study.

Authors:  Agata Janowska; Valentina Dini; Salvatore Panduri; Michela Macchia; Teresa Oranges; Marco Romanelli
Journal:  Int Wound J       Date:  2016-09       Impact factor: 3.315

3.  Evaluation of treatment response to autologous transplantation of noncultured melanocyte/keratinocyte cell suspension in patients with stable vitiligo.

Authors:  Mariana Gontijo Ramos; Daniel Gontijo Ramos; Camila Gontijo Ramos
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

Review 4.  Autologous non-cultured melanocyte-keratinocyte transplantation in the treatment of vitiligo: patient selection and perspectives.

Authors:  Dalia Bassiouny; Samia Esmat
Journal:  Clin Cosmet Investig Dermatol       Date:  2018-10-26

5.  A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte-keratinocyte transplantation.

Authors:  Dimin Zhang; Xiaodong Wei; Weisong Hong; Lifang Fu; Guopei Qian; Ai-E Xu
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

6.  Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review.

Authors:  V S Narayan; L L C van den Bol; N van Geel; M W Bekkenk; R M Luiten; A Wolkerstorfer
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-02-12       Impact factor: 6.166

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.